UM

Browse/Search Results:  1-10 of 12 Help

Filters                
Selected(0)Clear Items/Page:    Sort:
Immunogenomic analyses of advanced serous ovarian cancer reveal immune score is a strong prognostic factor and an indicator of chemosensitivity Journal article
Clinical Cancer Research, 2018,Volume: 24,Issue: 15,Page: 3560-3571
Authors:  Hao D.;  Liu J.;  Chen M.;  Li J.;  Wang L.;  Li X.;  Zhao Q.;  Di L.-J.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/21
Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes Journal article
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018,Volume: 14,Issue: 2,Page: 204-216
Authors:  Yang, Zheng;  Tam, Kin Yip
Favorite  |  View/Download:12/0  |  Submit date:2018/10/30
Combination  Egfr-tki  Nsclc  Chemotherapy  Targeted Therapy  Immunotherapy  
Venom-based peptide therapy: insights into anti-cancer mechanism Journal article
ONCOTARGET, 2017,Volume: 8,Issue: 59,Page: 100908-100930
Authors:  Ma, Rui;  Mahadevappa, Ravikiran;  Kwok, Hang Fai
Favorite  |  View/Download:13/0  |  Submit date:2018/10/30
Anticancer Mechanism  Venom  Metastasis  Targeted Therapy  Signaling Pathway  
The function and regulation of PD-L1 in immunotherapy Journal article
ADMET and DMPK, 2017,Volume: 5,Issue: 3,Page: 159-172
Authors:  Libin Guo;  Yao Lin;  HangFai Kwok
Favorite  |  View/Download:1/0  |  Submit date:2019/01/10
Nanoparticle Targeting of Neutrophils for Improved Cancer Immunotherapy Journal article
Advanced Healthcare Materials, 2016,Volume: 5,Issue: 9,Page: 1088-1093
Authors:  Chu D.;  Zhao Q.;  Yu J.;  Zhang F.;  Zhang H.;  Wang Z.
Favorite  |  View/Download:3/0  |  Submit date:2019/01/16
Albumin Nanoparticles  Antibodies  Immunotherapy  Neutrophils  Tumor  
Recent advances in the field of anti-cancer immunotherapy Journal article
BBA CLINICAL, 2015,Volume: 3,Page: 280-288
Authors:  Neves, H;  Kwok, HF
Favorite  |  View/Download:3/0  |  Submit date:2019/01/10
Immunotherapy  Anti-cancer Therapies  Antibodies  Cancer  
The prognostic significance of PD-L1 in bladder cancer Journal article
Oncology Reports, 2015,Volume: 33,Issue: 6,Page: 3075
Authors:  Huang Y.;  Zhang S.-D.;  McCrudden C.;  Chan K.-W.;  Lin Y.;  Kwok H.-F.
Favorite  |  View/Download:4/0  |  Submit date:2018/10/30
Bladder Cancer  Patient Survival  Prognostic Marker  Programmed Death Ligand-1  Therapeutic Targets  
神经母细胞瘤免疫治疗研究进展 Journal article
现代生物医学进展, 2015,Volume: 15,Issue: 10,Page: 1973-1976
Authors:  田永帅;  陈凤莲;  刘婕;  邹军辉;  万晓春;  赵琦
Favorite  |  View/Download:6/0  |  Submit date:2019/01/23
免疫治疗  免疫逃逸  神经节甘脂gd2  胰岛素样生长因子  
miRNA在防治非小细胞肺癌中的研究进展 Journal article
现代生物医学进展, 2015,Volume: 15,Issue: 10,Page: 1966-1970
Authors:  刘婕;  万晓春;  吕卫东;  李俊鑫;  赵琦
Favorite  |  View/Download:15/0  |  Submit date:2019/01/23
Microrna  非小细胞肺癌(nsclc)  诊断  治疗  预后  
Development of a 'mouse and human cross-reactive' affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy Journal article
Protein Engineering, Design and Selection, 2014,Volume: 27,Issue: 6,Page: 179-190
Authors:  Kwok H.F.;  Botkjaer K.A.;  Tape C.J.;  Huang Y.;  McCafferty J.;  Murphy G.
Favorite  |  View/Download:3/0  |  Submit date:2018/12/19
Anti-tace Antibody  Exosite  Immunoreactivity  Phage-display Randomization Libraries  Sub-nanomolar Affinity